International Journal of Rheumatic Diseases · 2019 · 10 citations · 22 references
MedicineCardiologyClinical SciencesClinical CardiologyHemodynamic ManagementSystemic PathologyAutonomic Nervous SystemCardiac AssessmentCardiac PhysiologyCardiovascular PhysiologyHeart Rate VariabilitySystemic SclerosisAutonomic Function MonitoringAutonomic Regulation Of The HeartBlood FlowCardiac Autonomic RegulationEndothelial Dysfunction AssessmentMyocardial Flow ReservePeripheral Autonomic DysfunctionSympathovagal Balance
AIM: Autonomic dysfunction (AD) is an early feature of systemic sclerosis (SSc). A regular endothelial function is a prerequisite for normal response of the myocardial blood flow (MBF) to cold pressure test (CPT). The aim of the study was to evaluate the relation between MBF and AD at rest and after CPT in asymptomatic SSc patients. METHODS: Twenty SSc patients and 10 age-, sex- and body mass index-matched healthy controls underwent cardiac magnetic resonance at rest and after CPT. All subjects underwent 24 hours ambulatory 3-channel electrocardiogram Holter to evaluate AD by heart rate variability. RESULTS: We did not observe any significant difference in MBF (mL/g/min) at rest and after CPT between SSc patients and healthy controls. Delta of MBF (difference between MBF after CPT and rest MBF) was lower (P = 0.039) in SSc patients than healthy controls (0.28 [0.04-0.40] vs 0.33 [0.24-0.54]). The low frequency/high frequency (LF/HF) was higher (P = 0.002) in SSc patients than healthy controls (3 [1.7-6] vs 1.8 [1.1-2.8]). The high frequencies (HF), modulated mainly by paraympathetic system, was lower (P = 0.003) in SSc patients than healthy controls (30 [16-42] vs 36.5 [24-44]). Sympathetic hyperactivity, due to reduction of parasympathetic activity (HF), is present in SSc patients. A negative correlation was observed between Delta of MBF and LF/HF (r = -0.572, P = 0.0031). CONCLUSION: AD, characterized by sympathovagal imbalance due to a reduced parasympathetic tone with high LF/HF ratio, could be responsible for the reduced myocardial vasodilatory response after CPT.
22
Task Force of the European Society of Cardiology the North A Electrophysiology · Circulation · 1996 · 16.9K citations
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis
E. Carwile LeRoy, Casilda G. Black, Raúl Fleischmajer et al. · 2001 · 4K citations
Medicine, Pathobiology, Pathology +10
F.H.J. van den Hoogen, Dinesh Khanna, Jaap Fransen et al. · Arthritis & Rheumatism · 2013 · 3.4K citations · Full text
A disease severity scale for systemic sclerosis: development and testing.
Thomas A. Medsger, Alan J. Silman, Virginia Steen et al. · PubMed · 1999 · 445 citations
Education, Biostatistics, Clinical Classification Systems +15